Patrycja Zalas-Wiecek
Overview
Explore the profile of Patrycja Zalas-Wiecek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boattini M, Bianco G, Bastos P, Mavromanolaki V, Maraki S, Spiliopoulou A, et al.
Int J Antimicrob Agents
. 2025 Mar;
:107478.
PMID: 40024606
Introduction: Despite being implicated in a wide spectrum of community- and healthcare-acquired infections, anaerobes have not yet been incorporated into systematic surveillance programs in Europe. Methods: We conducted a multicentre...
2.
Sekowska A, Czyzewski K, Jaremek K, Zalas-Wiecek P, Zajac-Spychala O, Wachowiak J, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064118
is a nosocomial pathogen that causes severe infections in immunocompromised patients. The aim of the study was to conduct a microbiological and clinical analysis of infections in children with malignancies...
3.
Boattini M, Bianco G, Iglesias Llorente L, Alonso Acero L, Nunes D, Seruca M, et al.
Int J Antimicrob Agents
. 2024 Feb;
63(5):107115.
PMID: 38367844
Introduction: The ESCPM group (Enterobacter species including Klebsiella aerogenes - formerly Enterobacter aerogenes, Serratia species, Citrobacter freundii complex, Providencia species and Morganella morganii) has not yet been incorporated into systematic...
4.
Zawitkowska J, Drabko K, Lejman M, Kowalczyk A, Czyzewski K, Dziedzic M, et al.
Sci Rep
. 2023 Dec;
13(1):22619.
PMID: 38114744
The most common complications related to the treatment of childhood acute lymphoblastic leukemia (ALL) are infections. The aim of the study was to analyze the incidence and mortality rates among...
5.
Styczynski T, Sadlok J, Richert-Przygonska M, Debski R, Zalas-Wiecek P, Czyzewski K, et al.
J Pediatr Hematol Oncol
. 2023 Jun;
45(8):e976-e979.
PMID: 37278583
Septic shock is a very rare manifestation of invasive fungal disease (IFD) in children after allogeneic hematopoietic cell transplantation (allo-HCT). The objective of this paper is analysis of two cases...
6.
Prazynska M, Zalas-Wiecek P, Bogiel T, Wlodarczyk Z, Deptula A, Wozniak M, et al.
Mycopathologia
. 2022 Dec;
188(1-2):135-141.
PMID: 36581774
Background: Candida auris is an emerging pathogen that constitutes a serious global health threat. It is difficult to identify without specific approaches, and it can be misidentified with standard laboratory...
7.
Zalas-Wiecek P, Plachta K, Gospodarek-Komkowska E
Pathogens
. 2022 Dec;
11(12).
PMID: 36558842
Cefiderocol (CFDC) is a novel, broad-spectrum siderophore cephalosporin with potential activity against multi-drug (MDR) and extensively drug-resistant (XDR) Enterobacterales, including carbapenem-resistant strains. We assessed the in vitro susceptibility to CFDC...
8.
Zalas-Wiecek P, Bogiel T, Gospodarek-Komkowska E
Pathogens
. 2022 Dec;
11(12).
PMID: 36558749
The aim of this study was to evaluate the usefulness of the Accelerate Pheno™ system (APS) (Accelerate Diagnostics, Denver, CO, USA) for rapid laboratory diagnosis of bloodstream infections. The study...
9.
Zawitkowska J, Drabko K, Czyzewski K, Dziedzic M, Jaremek K, Zalas-Wiecek P, et al.
Pathogens
. 2022 Oct;
11(10).
PMID: 36297147
Viral infections can be a serious complication of therapy in children with acute lymphoblastic leukemia (ALL). In this study, we focused on the incidence and the profile of viral infection...
10.
Richert-Przygonska M, Czyzewski K, Dziedzic M, Zalas-Wiecek P, Gryniewicz-Kwiatkowska O, Gietka A, et al.
Pediatr Infect Dis J
. 2022 Jul;
41(10):846-850.
PMID: 35797710
Background: Infections caused by Stenotrophomonas maltophilia (SM) have documented high mortality rate in immunocompromised patients. Aim: This nationwide multicenter study was performed to analyze the epidemiology of SM infections in...